While investors in the tobacco space have tended to be more focused on dividends over the years, Philip Morris International ...

Philip Morris delivered strong Q4 results, driven by surging demand for products like IQOS and ZYN. Read why I maintain a ...

I am upgrading Japan Tobacco stock from Hold to Buy, after considering its satisfactory 2024 performance and its positive ...

Overall revenue was down 5.2% to $32.24 billion, which reflected primarily a reduction in fiscal 2024 revenue following BAT's 2023 divestitures of business in Russia and Belarus in response to ...

Tobacco harm reduction advocates in the Philippines lauded the U.S. Food and Drug Administration’s marketing authorizations ...

Local proponents of tobacco harm reduction have welcomed the recent U.S. Food and Drug Administration’s (FDA) marketing ...

Denver City Council’s crusade against flavored nicotine products continues to vex those of us who, as a matter of civic ...

Detailed price information for Philip Morris International Inc (PM-N) from The Globe and Mail including charting and trades.

Citi analyst Simon Hales reiterated a Buy rating on British American Tobacco (BATS – Research Report) today and set a price target of £36.00.

Last month, the FDA authorized the sale of 10 Zyn flavors, marking the first time the agency has backed the public health ...

Multi-national corporations, home-grown companies, industry groups, advocacy organizations, local government, lobbying firms ...